Zhejiang Jingxin Pharmaceutical Co., Ltd.
Symbol: 002020.SZ
SHZ
12.29
CNYDzisiejsza cena rynkowa
16.3059
Wskaźnik P/E
-1.6917
Wskaźnik PEG
10.58B
Kapitalizacja MRK
- 0.02%
Rentowność DIV
Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020-SZ) Sprawozdania finansowe
Bilans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 7335.53 | 2019.9 | 1915.4 | 1977.2 | |||||||||||||||||||||||
balance-sheet.row.short-term-investments | 1127.56 | 609.3 | 366.9 | 422.4 | |||||||||||||||||||||||
balance-sheet.row.net-receivables | 2431.47 | 664 | 570 | 586.7 | |||||||||||||||||||||||
balance-sheet.row.inventory | 2703.54 | 652.7 | 773.7 | 649.1 | |||||||||||||||||||||||
balance-sheet.row.other-current-assets | 299.73 | 17.1 | 22.1 | 16.5 | |||||||||||||||||||||||
balance-sheet.row.total-current-assets | 12770.27 | 3353.7 | 3281.2 | 3229.5 | |||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 8656.05 | 2309.8 | 1632.1 | 1262.9 | |||||||||||||||||||||||
balance-sheet.row.goodwill | 1393.94 | 348.5 | 348.5 | 257.9 | |||||||||||||||||||||||
balance-sheet.row.intangible-assets | 1617.31 | 401.3 | 418.6 | 137.7 | |||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 3011.25 | 749.7 | 767.1 | 395.6 | |||||||||||||||||||||||
balance-sheet.row.long-term-investments | 2754.28 | 1471.1 | 218.9 | 119.5 | |||||||||||||||||||||||
balance-sheet.row.tax-assets | 297.88 | 81 | 75.1 | 62.5 | |||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 4007.56 | 21.2 | 1388.1 | 1345.3 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 18727.02 | 4632.8 | 4081.4 | 3185.8 | |||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.total-assets | 31497.29 | 7986.6 | 7362.6 | 6415.4 | |||||||||||||||||||||||
balance-sheet.row.account-payables | 3316.2 | 610.8 | 719.1 | 435.1 | |||||||||||||||||||||||
balance-sheet.row.short-term-debt | 1704.65 | 621.3 | 253.3 | 161.9 | |||||||||||||||||||||||
balance-sheet.row.tax-payables | 199.19 | 44.3 | 105.4 | 95 | |||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 139.56 | 31.2 | 43 | 6.6 | |||||||||||||||||||||||
Deferred Revenue Non Current | 1091.72 | 268.8 | 270.6 | 128.7 | |||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 254.92 | - | - | - | |||||||||||||||||||||||
balance-sheet.row.other-current-liab | 805.52 | 789.3 | 761.9 | 4.7 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 1227.33 | 102.8 | 375.2 | 192.6 | |||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 139.56 | 31.2 | 43 | 6.5 | |||||||||||||||||||||||
balance-sheet.row.total-liab | 9357.68 | 2177.6 | 2190.6 | 1577.7 | |||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.common-stock | 3444.12 | 861 | 861 | 905.3 | |||||||||||||||||||||||
balance-sheet.row.retained-earnings | 9981.01 | 2540.1 | 2228.8 | 1871.1 | |||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 4893.06 | 388 | 336.1 | 285.9 | |||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 3443.45 | 1723.3 | 1720.2 | 1755.1 | |||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 21761.63 | 5512.4 | 5146.1 | 4817.4 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 31497.29 | 7986.6 | 7362.6 | 6415.4 | |||||||||||||||||||||||
balance-sheet.row.minority-interest | 109.17 | 27.8 | 25.8 | 20.2 | |||||||||||||||||||||||
balance-sheet.row.total-equity | 21870.8 | 5540.2 | 5172 | 4837.7 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 31497.29 | - | - | - | |||||||||||||||||||||||
Total Investments | 3881.85 | 2080.4 | 585.8 | 541.9 | |||||||||||||||||||||||
balance-sheet.row.total-debt | 1844.21 | 652.5 | 296.3 | 168.5 | |||||||||||||||||||||||
balance-sheet.row.net-debt | -4363.76 | -758.2 | -1252.2 | -1386.3 |
Rachunek przepływów pieniężnych
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 638.91 | 618.9 | 667.8 | 614.7 | ||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 10.99 | 221.5 | 166.9 | 143.6 | ||||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 2.8 | -12.2 | -5.8 | ||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | -488 | 12.2 | 5.8 | ||||||||||||||||||||||
cash-flows.row.change-in-working-capital | 29.56 | -45 | 21.3 | -391.7 | ||||||||||||||||||||||
cash-flows.row.account-receivables | -93.48 | -93.5 | -250.9 | -208.6 | ||||||||||||||||||||||
cash-flows.row.inventory | 123.04 | 123 | -103 | -147.8 | ||||||||||||||||||||||
cash-flows.row.account-payables | 0 | -74.6 | 387.4 | -41.8 | ||||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 0 | -12.2 | 6.5 | ||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 275.34 | 514.5 | -0.3 | -1.5 | ||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 954.8 | 0 | 0 | 0 | ||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -339.78 | -519.5 | -515.6 | -404.4 | ||||||||||||||||||||||
cash-flows.row.acquisitions-net | 9.85 | 10.3 | 5.2 | 8.3 | ||||||||||||||||||||||
cash-flows.row.purchases-of-investments | -870.2 | -1175.2 | -1058 | -861.7 | ||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 1011.18 | 915 | 833.9 | 1407.9 | ||||||||||||||||||||||
cash-flows.row.other-investing-activites | 311.97 | 0 | -3.2 | -5.3 | ||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -189.34 | -769.4 | -737.7 | 144.7 | ||||||||||||||||||||||
cash-flows.row.debt-repayment | -339.22 | -35 | -150 | -300.3 | ||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
cash-flows.row.dividends-paid | -258.11 | -258.3 | -258.6 | -232.2 | ||||||||||||||||||||||
cash-flows.row.other-financing-activites | 593.64 | -4 | 220.5 | 653.3 | ||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -180.91 | -245.6 | -188 | 120.8 | ||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 5.78 | 2.7 | 14.9 | -3.8 | ||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 684.27 | -77.8 | -55 | 626.8 | ||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 5962.04 | 1410.6 | 1463.7 | 1512.8 | ||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 5277.77 | 1488.5 | 1518.7 | 886 | ||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 954.8 | 824.7 | 855.8 | 365 | ||||||||||||||||||||||
cash-flows.row.capital-expenditure | -339.78 | -519.5 | -515.6 | -404.4 | ||||||||||||||||||||||
cash-flows.row.free-cash-flow | 615.02 | 305.2 | 340.2 | -39.4 |
Wiersz rachunku zysków i strat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 4082.46 | 3952.1 | 3779.8 | 3336 | |||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 2026.66 | 2048.3 | 1766.1 | 1472.8 | |||||||||||||||||||||||
income-statement-row.row.gross-profit | 2055.8 | 1903.8 | 2013.7 | 1863.2 | |||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
income-statement-row.row.research-development | 410.79 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 78.1 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 790.89 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-expenses | -21.94 | 6.4 | 135.7 | 99.8 | |||||||||||||||||||||||
income-statement-row.row.operating-expenses | 1442.43 | 1324.6 | 1354.4 | 1250.3 | |||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 3469.09 | 3372.9 | 3120.5 | 2723 | |||||||||||||||||||||||
income-statement-row.row.interest-income | 43.91 | 60.3 | 65.6 | 48.1 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 6.56 | 7.3 | 6 | 3.7 | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 790.89 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 77.27 | 134.9 | -6.3 | 1.5 | |||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | -21.94 | 6.4 | 135.7 | 99.8 | |||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 77.27 | 134.9 | -6.3 | 1.5 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 6.56 | 7.3 | 6 | 3.7 | |||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 82.38 | 221.5 | 182.9 | 170.6 | |||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 740.39 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.operating-income | 658.01 | 579.2 | 756.6 | 693 | |||||||||||||||||||||||
income-statement-row.row.income-before-tax | 735.28 | 714.1 | 750.3 | 694.5 | |||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 90.4 | 84.6 | 82.5 | 79.8 | |||||||||||||||||||||||
income-statement-row.row.net-income | 638.91 | 618.9 | 662.3 | 612.5 |
Często zadawane pytania
Ile wynosi Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) aktywów ogółem?
Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) całkowite aktywa to 7986556907.000.
Jaki jest roczny przychód przedsiębiorstwa?
Roczny przychód to 2117348157.000.
Jaka jest marża zysku firmy?
Marża zysku firmy to 0.504.
Czym są wolne przepływy pieniężne firmy?
Wolne przepływy pieniężne to 0.718.
Jaka jest marża zysku netto przedsiębiorstwa?
Marża zysku netto to 0.157.
Jaki jest całkowity przychód firmy?
Całkowity przychód to 0.161.
Co to jest Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) zysk netto (dochód netto)?
Zysk netto (dochód netto) wynosi 618898033.000.
Jakie jest całkowite zadłużenie firmy?
Całkowite zadłużenie to 652489982.000.
Ile wynoszą koszty operacyjne?
Wydatki operacyjne to 1324586158.000.
Jaka jest wartość gotówki firmy?
Środki pieniężne przedsiębiorstwa to 2069633166.000.